tirzepatide fda approval timeline Zepbound (Tirzepatide, GLP1RA), is the first approved medication to treat moderate to severe OBSTRUCTIVE SLEEP APNEA (OSA) in adults with obesity What Is Tirzepatide Derived From:

Semaglutide a once-weekly human GLP-1 analog does not reduce the bioavailability of the combined oral contraceptive, ethinylestradiol/levonorgestrel

Some patients find that ginger tea, peppermint, or eating a small amount of bland food shortly before or after their injection reduces symptoms

And a beta subunit that gives HCG its unique biological activity

The results of the TRANSCEND-T2D-1 trial, published in March 2026, showed that participants with type 2 diabetes mellitus, who took retatrutide 12mg, lost an average of 16.8% of their body weight at 40 weeks

Drugs of Today

Remember, some of these medications are also prescribed for type 2 diabetes